Quick Answer
Aspira Women’s Health Inc. reported Cash and Equivalents of $1.77 million for fiscal year 2024.
Aspira Women’s Health Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2024 | $1.77M | -31.9% |
| 2023 | $2.60M | -80.5% |
| 2022 | $13.31M | -64.2% |
| 2021 | $37.18M | +123.6% |
| 2020 | $16.63M | +200.3% |
| 2017 | $5.54M | +5.7% |
| 2016 | $5.24M | -71.9% |
| 2015 | $18.64M | -18.8% |
| 2014 | $22.96M | -22.2% |
| 2013 | $29.50M | +268.5% |
| 2012 | $8.01M | -64.4% |
| 2011 | $22.48M | -1.9% |
| 2010 | $22.91M | +566.1% |
| 2009 | $3.44M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.81M | +78.6% | +146.5% |
| June 30, 2025 | $1.54M | +60.6% | -53.4% |
| March 31, 2025 | $3.31M | -3.0% | +87.2% |
| December 31, 2024 | $1.77M | -31.9% | -17.1% |
| September 30, 2024 | $2.13M | -58.2% | +121.7% |
| June 30, 2024 | $962.0K | -77.3% | -71.8% |
| March 31, 2024 | $3.41M | -54.7% | +31.4% |
| December 31, 2023 | $2.60M | -80.5% | -49.1% |
- Aspira Women’s Health Inc. showed a decrease of -31.9% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2009–2024 period, Aspira Women’s Health Inc.’s cash and equivalents has declined by 48.6% (from $3.44 million to $1.77 million).
- The most recent figure is from Aspira Women’s Health Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 27, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: